MYCEPT 500MG TABLET

Mycept 500 mg Tablet is an anti-inflammatory drug with an active ingredient, Mycophenolate mofetil. It falls under the inosine monophosphate dehydrogenase (IMPDH) inhibitor class. It is used to stop organ rejection in patients who have had the organs of a donor (such as heart, kidney transplantation, or liver). It is usually prescribed as part of a combination treatment, which includes other immunosuppressive medications.
The use of this drug is not recommended during pregnancy because of the risk of miscarriage and congenital disabilities. It is not recommended for pregnant women unless there are other alternatives and the benefits outweigh any risks. Women who are born should make use of effective contraception while using this tablet to prevent pregnancies. Due to the reduced effectiveness and possible contracting, live vaccines shouldn’t be administered while a patient takes Mycept 500mg Tablet. Patients taking this medication must not give blood during treatment and, at minimum, six weeks after having stopped treatment. It is a way to ensure that the drug is entirely cleared out of the body before giving blood.
It is recommended not to use this medication if you have an allergy to it or other ingredients. Inform your physician about heart or liver problems before starting the treatment. Because this medication reduces the body’s immune system, it could increase the risk of developing skin cancer. People should minimize their exposure to the sun or ultraviolet (UV) radiation. Consult your physician immediately in case of bruising on your face, fever, unprovoked fatigue, dizziness, discoloration of the skin or eyes, vision impairment, reduced urinary output, or seizures after taking this medication. Mycept 500 mg Tablet is an anti-inflammatory medication. It could affect the baby’s developing immune system and should not be used during breastfeeding. In certain instances, alternatives to drugs that have an improved safety profile when breastfeeding could be thought of as.